L E Kandalaft
Overview
Explore the profile of L E Kandalaft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dafni U, Martin-Lluesma S, Balint K, Tsourti Z, Vervita K, Chenal J, et al.
Eur J Cancer
. 2020 Nov;
142:63-82.
PMID: 33221598
Background: Therapeutic cancer vaccination is an area of interest, even though promising efficacy has not been demonstrated so far. Design: A systematic review and meta-analysis was conducted to evaluate vaccines'...
2.
Dafni U, Michielin O, Lluesma S, Tsourti Z, Polydoropoulou V, Karlis D, et al.
Ann Oncol
. 2019 Oct;
30(12):1902-1913.
PMID: 31566658
Adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) has been tested in advanced melanoma patients at various centers. We conducted a systematic review and meta-analysis to assess its efficacy...
3.
Digklia A, Duran R, Homicsko K, Kandalaft L, Hocquelet A, Orcurto A, et al.
Cardiovasc Intervent Radiol
. 2018 Sep;
42(9):1221-1229.
PMID: 30209564
The therapeutic options in the treatment of cancer therapy have been recently significantly increased with systemic immune-targeted therapies. Novel immunotherapy approaches based on immune checkpoint blockade or engineered cytotoxic T...
4.
Guo Y, Hu J, Wang Y, Peng X, Min J, Wang J, et al.
Eur J Cancer
. 2018 Jan;
90:111-121.
PMID: 29304474
Background: Tumour endothelial marker 1 (TEM1/endosialin/CD248) is a tumour-restricted cell-surface protein expressed by human sarcomas. We previously developed a high-affinity human single-chain variable fragment (scFv)-Fc fusion protein (78Fc) against TEM1...
5.
Coukos G, Tanyi J, Kandalaft L
Ann Oncol
. 2016 May;
27 Suppl 1:i11-i15.
PMID: 27141063
Ovarian cancer (OC) is the most important cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease. Although surgery and chemotherapy can improve survival, the 5-year...